We are a Faram pharmaceutical wholesaler that supplies pharmacies and other pharmaceutical wholesalers. We enjoy a very good reputation on the pharmaceutical market. We follow the principles of Good Distribution Practice.
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.74.Z - Wholesale trade
46.75.Z - Wholesale trade
46.76.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
49.41.Z - Road freight transport
52.10.B - Warehousing and storage of other goods
52.21.Z - Support activities for land transport
70.22.Z - Head office activities and management consultancy
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,1 | 1,5 | 0,4 | -74,5 |
EBITDA | 1,1 | 1,5 | 0,4 | -73,2 |
Short time liabilities | 4,3 | 4,7 | 1,4 | -70,1 |
Equity capital | 1,8 | 2,9 | 3,2 | 10,5 |
Operating profit (EBIT) | 1,1 | 1,5 | 0,4 | -74,5 |
Assets | 6,1 | 7,6 | 4,6 | -39,5 |
Net profit (loss) | 0,9 | 1,2 | 0,3 | -75,3 |
Cash | 2,3 | 2 | 0,6 | -68,4 |
Net income from sale | 20,9 | 30,6 | 21,2 | -30,5 |
Liabilities and provisions for liabilities | 4,3 | 4,7 | 1,4 | -70,1 |
Working assets | 6,1 | 7,5 | 4,5 | -39,7 |
Depreciation | 0 | 0 | 0 | 140 |
% | % | % | p.p. | |
Profitability of capital | 49,8 | 42,5 | 9,5 | -33 |
Equity capital to total assets | 30,1 | 37,9 | 69,3 | 31,4 |
Gross profit margin | 5,3 | 5 | 1,8 | -3,2 |
EBITDA Margin | 5,3 | 5 | 1,9 | -3,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 75 | 56 | 24 | -32 |
Current financial liquidity indicator | 1.431296467781067 | 1.5905150175094604 | 3.2053029537200928 | 1,6 |
Net dept to EBITDA | -1.6594148874282837 | -1.2360098361968994 | -1.5642852783203125 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane